LUMASIRAN TREATMENT IMMEDIATELY AFTER BIRTH IN PRIMARY HYPEROXALURIA TYPE 1: NEVER TOO SOON

被引：0
|
作者：
Peruzzi, Licia [1 ]
Leporati, Marta [2 ]
Petrarulo, Michele [2 ]
Martins, Vitor Dias [1 ]
Coscia, Alessandra [3 ]
Marozio, Luca [4 ]
Camilla, Roberta [1 ]
Mattozzi, Francesca [1 ]
Gianoglio, Bruno [1 ]
机构：
[1] Regina Margherita Childrens Hosp, Pediat Nephrol Turin, Regina, SK, Italy
[2] Osped Mauriziano Umberto 1, Analyt Chem & Kidney Stone Dis Unit, Lab Anal, Turin, Italy
[3] Univ Turin, Neonatal Intens Care Unit, Turin, Italy
[4] Univ Turin, Obstet & Gynecol, Turin, Italy
来源：
PEDIATRIC NEPHROLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Fr-P 151
引用
收藏
页码：S198 / S199
页数：2
相关论文
共 50 条
  • [1] OXALATEMETABOLISMIN PRIMARY HYPEROXALURIA TYPE 1 TREATED WITH LUMASIRAN IMMEDIATELY AFTER BIRTH: STILL NOT EARLY ENOUGH
    Peruzzi, Licia
    Leporati, Marta
    Petrarulo, Michele
    Martins, Vitor Dias
    Marozio, Luca
    Coscia, Alessandra
    Camilla, Roberta
    Mattozzi, Francesca
    Deaglio, Silvia
    Gianoglio, Bruno
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I239 - I240
  • [2] Lumasiran: A Review in Primary Hyperoxaluria Type 1
    Connie Kang
    Drugs, 2024, 84 : 219 - 226
  • [3] Lumasiran: A Review in Primary Hyperoxaluria Type 1
    Kang, Connie
    DRUGS, 2024, 84 (02) : 255 - 255
  • [4] Concomitant Treatment With Lumasiran and Nedosiran in a Child With Primary Hyperoxaluria Type 1
    Braekman, Eline
    Raes, Ann
    De Bruyne, Ruth
    Verloo, Patrick
    Prytula, Agnieszka
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (02): : 620 - 621
  • [5] Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1
    Hulton, Sally-Anne
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (7-10): : 189 - 198
  • [6] Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
    Shah, Viral N.
    Pyle, Laura
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20):
  • [7] Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
    Garrelfs, Sander F.
    Frishberg, Yaacov
    Hulton, Sally A.
    Koren, Michael J.
    O'Riordan, William D.
    Cochat, Pierre
    Deschenes, Georges
    Shasha-Lavsky, Hadas
    Saland, Jeffrey M.
    van't Hoff, William G.
    Fuster, Daniel G.
    Magen, Daniella
    Moochhala, Shabbir H.
    Schalk, Gesa
    Simkova, Eva
    Groothoff, Jaap W.
    Sas, David J.
    Meliambro, Kristin A.
    Lu, Jiandong
    Sweetser, Marianne T.
    Garg, Pushkal P.
    Vaishnaw, Akshay K.
    Gansner, John M.
    McGregor, Tracy L.
    Lieske, John C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1216 - 1226
  • [8] Primary Hyperoxaluria Diagnosed After Second Kidney Transplantation and Treated With Lumasiran: Never Say Never!
    Sarkar, Mrinalini
    Kendrick, Elizabeth A.
    Lum, Erik L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 838 - 838
  • [9] Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1
    Connie Kang
    Drugs, 2024, 84 (3) : 371 - 371
  • [10] Variable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1
    Saffe, Sina
    Doerry, Katja
    Buscher, Anja K.
    Hansen, Matthias
    Rohmann, Melanie
    Kanzelmeyer, Nele
    Latta, Kay
    Kemper, Markus J.
    Loos, Sebastian
    PEDIATRIC NEPHROLOGY, 2025, : 1929 - 1937
12345